Sleep Disturbance in Heavy Marijuana Users

Overview

Journal Sleep

Publisher Oxford University Press

Specialty Psychiatry

Date 2008 Jun 14

PMID 18548836

Citations 70

Authors

Karen I Bolla

Suzanne R Lesage

Charlene E Gamaldo

David N Neubauer

Frank R Funderburk

Jean Lud Cadet

Paula M David

Antonio Verdejo-Garcia

Amy R Benbrook

Affiliations

Soon will be listed here.

Abstract

Study Objective: To determine if recently abstinent, heavy marijuana (MJ) users show differences in polysomnographic (PSG) measures compared with a drug-free control group.

Design: A group of carefully selected heavy MJ users were chosen for study inclusion and matched to a drug-free control group. Questionnaire data were collected prior to cessation of MJ use. PSG studies were conducted during 2 consecutive nights after discontinuation of MJ use in our core sleep laboratory.

Setting: Baltimore Maryland, General Clinical Research Center (GCRC) core sleep lab.

Participants: 17 heavy MJ users discontinuing MJ use and 14 drug-free controls. Men and women were studied, 18 to 30 years. The MJ users reported no other drug use and alcohol use was negligible in both groups. Urine was positive for metabolites of cannabis only.

Measurements And Results: The MJ users showed differences in PSG measures (lower total sleep times, and less slow wave sleep than the control group) on both nights; they also showed worse sleep efficiency, longer sleep onset, and shorter REM latency than the control group on Night 2. More sleep continuity parameters were significantly worse for the MJ group than the control group on Night 2 versus Night 1, indicating that sleep in the MJ group was relatively worse on Night 2 compared to Night 1. The MJ group did not show improved sleep after an adaptation night as expected. Withdrawal symptoms, craving, and depression did not appear to influence these findings.

Conclusions: During discontinuation of heavy MJ use, PSG measures of sleep disturbance were detected in MJ users compared with a drug-free control group. While this preliminary study cannot identify the extent to which these group differences were present before abstinence, poor sleep quality either prior to or after MJ discontinuation could result in treatment failure for MJ users. Further investigation is necessary to determine the association between the use and cessation of MJ and sleep disturbance.

Citing Articles

Association between early life second-hand smoke exposure on child sleep and psychoactive substance use on adult sleep patterns in an urban informal settlement in Uganda.

Wafula S, Namakula L, Isunju J, Mugambe R, Ssekamatte T, Musoke D PLoS One. 2025; 20(1):e0312127.

PMID: 39752375 PMC: 11698410. DOI: 10.1371/journal.pone.0312127.

Application of life history theory to explain the association between childhood maltreatment and adulthood sleep problems in Chinese men with drug abuse: multiple mediating roles of emotion regulation, future-oriented coping, and anxiety.

Feng C, Wu A, Chen Y, Xing Y, Zhai R, Zhang X Eur J Psychotraumatol. 2024; 15(1):2411881.

PMID: 39415717 PMC: 11488165. DOI: 10.1080/20008066.2024.2411881.

Disrupted Circadian Rhythms and Substance Use Disorders: A Narrative Review.

Sharma P, Nelson R Clocks Sleep. 2024; 6(3):446-467.

PMID: 39189197 PMC: 11348162. DOI: 10.3390/clockssleep6030030.

Substance Use and Sleep Problems in Patients With Psychotic Disorders.

Cederlof E, Holm M, Ahti J, Lahteenvuo M, Hietala J, Hakkinen K Schizophr Bull Open. 2024; 4(1):sgac073.

PMID: 39145344 PMC: 11207820. DOI: 10.1093/schizbullopen/sgac073.

The impact of cannabis use proximal to sleep and cannabinoid metabolites on sleep architecture.

Althoff M, Kinney G, Aloia M, Sempio C, Klawitter J, Bowler R J Clin Sleep Med. 2024; 20(10):1615-1625.

PMID: 38804689 PMC: 11446118. DOI: 10.5664/jcsm.11212.

References

Murillo-Rodriguez E, Blanco-Centurion C, Sanchez C, Piomelli D, Shiromani P . Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep. 2004; 26(8):943-7. DOI: 10.1093/sleep/26.8.943. View

McLellan A, Luborsky L, Woody G, OBrien C . An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980; 168(1):26-33. DOI: 10.1097/00005053-198001000-00006. View

Feinberg I, Jones R, Walker J, Cavness C, Floyd T . Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. Clin Pharmacol Ther. 1976; 19(6):782-94. DOI: 10.1002/cpt1976196782. View

Heishman S, Singleton E . Assessment of cannabis craving using the Marijuana Craving Questionnaire. Methods Mol Med. 2006; 123:209-16. DOI: 10.1385/1-59259-999-0:209. View

Wong M, Brower K, Fitzgerald H, Zucker R . Sleep problems in early childhood and early onset of alcohol and other drug use in adolescence. Alcohol Clin Exp Res. 2004; 28(4):578-87. DOI: 10.1097/01.alc.0000121651.75952.39. View

Muzur A, Pace-Schott E, Hobson J . The prefrontal cortex in sleep. Trends Cogn Sci. 2002; 6(11):475-481. DOI: 10.1016/s1364-6613(02)01992-7. View

Budney A, Hughes J, Moore B, Vandrey R . Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004; 161(11):1967-77. DOI: 10.1176/appi.ajp.161.11.1967. View

Eldreth D, Matochik J, Cadet J, Bolla K . Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage. 2004; 23(3):914-20. DOI: 10.1016/j.neuroimage.2004.07.032. View

Haney M, Hart C, Ward A, Foltin R . Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology (Berl). 2002; 165(2):157-65. DOI: 10.1007/s00213-002-1210-3. View

10.

Johnson E, Breslau N . Sleep problems and substance use in adolescence. Drug Alcohol Depend. 2001; 64(1):1-7. DOI: 10.1016/s0376-8716(00)00222-2. View

11.

FREEMON F . The effect of chronically administered delta-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers. Drug Alcohol Depend. 1982; 10(4):345-53. DOI: 10.1016/0376-8716(82)90036-9. View

12.

Bolla K, Eldreth D, Matochik J, Cadet J . Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage. 2005; 26(2):480-92. DOI: 10.1016/j.neuroimage.2005.02.012. View

13.

. Recording and scoring leg movements. The Atlas Task Force. Sleep. 1993; 16(8):748-59. View

14.

Kouri E, Pope Jr H . Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol. 2000; 8(4):483-92. DOI: 10.1037//1064-1297.8.4.483. View

15.

Morgan P, Pace-Schott E, Sahul Z, Coric V, Stickgold R, Malison R . Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia. Drug Alcohol Depend. 2005; 82(3):238-49. DOI: 10.1016/j.drugalcdep.2005.09.014. View

16.

Bolla K, Brown K, Eldreth D, Tate K, Cadet J . Dose-related neurocognitive effects of marijuana use. Neurology. 2002; 59(9):1337-43. DOI: 10.1212/01.wnl.0000031422.66442.49. View

17.

Heatherton T, Kozlowski L, Frecker R, Fagerstrom K . The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86(9):1119-27. DOI: 10.1111/j.1360-0443.1991.tb01879.x. View

18.

Feinberg I, Jones R, Walker J, Cavness C, March J . Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man. Clin Pharmacol Ther. 1975; 17(4):458-66. DOI: 10.1002/cpt1975174458. View

19.

Drummond S, Smith M, Orff H, Chengazi V, Perlis M . Functional imaging of the sleeping brain: review of findings and implications for the study of insomnia. Sleep Med Rev. 2004; 8(3):227-42. DOI: 10.1016/j.smrv.2003.10.005. View

20.

Horne J, Ostberg O . A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976; 4(2):97-110. View